BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9054379)

  • 1. Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-alpha-mediated cytotoxicity.
    Cai Z; Bettaieb A; Mahdani NE; Legrès LG; Stancou R; Masliah J; Chouaib S
    J Biol Chem; 1997 Mar; 272(11):6918-26. PubMed ID: 9054379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of human breast adenocarcinoma MCF7 resistance to tumor necrosis factor-induced cell death. Lack of correlation between JNK activation and ceramide pathway.
    Ameyar M; Atfi A; Cai Z; Stancou R; Shatrov V; Bettaïeb A; Chouaïb S
    J Biol Chem; 1998 Oct; 273(44):29002-8. PubMed ID: 9786905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
    Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
    Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in TNF-alpha signal transduction in resistant human papillary thyroid carcinoma cells.
    Pang XP; Ross NS; Hershman JM
    Thyroid; 1996 Aug; 6(4):313-7. PubMed ID: 8875753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells.
    Jäättelä M; Benedict M; Tewari M; Shayman JA; Dixit VM
    Oncogene; 1995 Jun; 10(12):2297-305. PubMed ID: 7540278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells.
    Yang Z; Costanzo M; Golde DW; Kolesnick RN
    J Biol Chem; 1993 Sep; 268(27):20520-3. PubMed ID: 8376408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells.
    Chen CC; Sun YT; Chen JJ; Chang YJ
    Mol Pharmacol; 2001 Mar; 59(3):493-500. PubMed ID: 11179444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function.
    Cai Z; Capoulade C; Moyret-Lalle C; Amor-Gueret M; Feunteun J; Larsen AK; Paillerets BB; Chouaib S
    Oncogene; 1997 Dec; 15(23):2817-26. PubMed ID: 9419972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
    Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
    Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IkappaB alpha overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-kappaB activation but not tumor necrosis factor-alpha-induced apoptosis.
    Cai Z; Körner M; Tarantino N; Chouaib S
    J Biol Chem; 1997 Jan; 272(1):96-101. PubMed ID: 8995233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyltransferase inhibitor S-adenosyl-L-homocysteine sensitizes human breast carcinoma MCF7 cells and related TNF-resistant derivatives to TNF-mediated cytotoxicity via the ceramide-independent pathway.
    Shatrov VA; Ameyar M; Cai Z; Bettaieb A; Chouaib S
    Eur Cytokine Netw; 1999 Jun; 10(2):247-52. PubMed ID: 10400831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramide is not a signal for tumor necrosis factor-induced gene expression but does cause programmed cell death in human vascular endothelial cells.
    Slowik MR; De Luca LG; Min W; Pober JS
    Circ Res; 1996 Oct; 79(4):736-47. PubMed ID: 8831497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-alpha.
    Gerritsen ME; Shen CP; Perry CA
    Am J Pathol; 1998 Feb; 152(2):505-12. PubMed ID: 9466577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase A2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells.
    Jayadev S; Hayter HL; Andrieu N; Gamard CJ; Liu B; Balu R; Hayakawa M; Ito F; Hannun YA
    J Biol Chem; 1997 Jul; 272(27):17196-203. PubMed ID: 9202042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acid sphingomyelinase inhibitor SR33557 counteracts TNF-alpha-mediated potentiation of IL-1beta-induced NF-kappaB activation in the insulin-producing cell line Rinm5F.
    Saldeen J; Jaffrézou JP; Welsh N
    Autoimmunity; 2000 Dec; 32(4):241-54. PubMed ID: 11191283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase.
    Luberto C; Hassler DF; Signorelli P; Okamoto Y; Sawai H; Boros E; Hazen-Martin DJ; Obeid LM; Hannun YA; Smith GK
    J Biol Chem; 2002 Oct; 277(43):41128-39. PubMed ID: 12154098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha-induced release of plasminogen activator inhibitor-1 from human umbilical vein endothelial cells: involvement of intracellular ceramide signaling event.
    Soeda S; Tsunoda T; Kurokawa Y; Shimeno H
    Biochim Biophys Acta; 1998 Nov; 1448(1):37-45. PubMed ID: 9824663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite effects of tumor necrosis factor alpha on the sphingomyelin-ceramide pathway in two myeloid leukemia cell lines: role of transverse sphingomyelin distribution in the plasma membrane.
    Bettaieb A; Record M; Côme MG; Bras AC; Chap H; Laurent G; Jaffrézou JP
    Blood; 1996 Aug; 88(4):1465-72. PubMed ID: 8695867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway.
    Adam D; Wiegmann K; Adam-Klages S; Ruff A; Krönke M
    J Biol Chem; 1996 Jun; 271(24):14617-22. PubMed ID: 8663014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells.
    Chiao C; Bader T; Stenger JE; Baldwin W; Brady J; Barrett JC
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1125-32. PubMed ID: 11522182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.